Viral RNA biosensor stickers for the mass Covid-19 testing
Think of every household in the world having a small box of biosensor stickers — similar to a box of bandaids.
LogicInk biosensors can be sent in advance, and be used easily whenever and as frequently as needed, effectively giving us a shot at the detection of a disease vector as soon as it manifests — for both COVID-19 and the next pandemics to come.Sign up for our newsletter →
Making the invisible visible
We can't effectively solve for what we cannot sense. Countries shut down as the brute force approach for COVID-19 defense, producing dire consequences to our quality of life and functioning of our economies.
With LogicInk's viral RNA biosensor, we make the invisible visible, allowing safe reopening of economies for everyone – businesses, employees, and customers.
Mass-produced sticker enables safe businesses
Through scalable, fast, and reliable COVID-19 test, LogicInk's viral RNA biosensor enables our B2B partners let their customers and employees safely come back to their business – hotels, stadiums, large and small social spaces, offices, etc.
Building a scalable, fast, and reliable COVID-19 test platform for the entire human population
We know this is ambitious goal but we can get there, and we need your help. Please reach out to us with what you can provide – let's build the future together.
Test that entire population understands
Leveraging its patent-pending biosensor capabilities, LogicInk’s new wearable signal would allow for entire populations to self-administer, interpret the results, and report the presence of SARS-CoV-2 RNA (COVID- 19) simply by looking for the appropriate color combination.
Easy to mass-produce: affordable, repeatable test
The test can be repeated as many times as needed, without interaction with medical personnel. Because LogicInk biosensor stickers can be easily mass-produced, are easy to apply, and do not require any testing cartridges or lateral flow strips, it's feasible logistically and financially to be quickly applied to entire populations.
Presymptomatic and asymptomatic altogether
LogicInk’s biosensor sticker focuses on signaling early detection, which is critically important to stemming the outbreak and transmission of all viruses, and COVID-19 has proven to be no different. Evidence from the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) suggests it can be detected in people 1-3 days before their symptoms appear. Presymptomatic and asymptomatic carriers can also unknowingly transmit the virus, making the need for ubiquitous, easily accessible testing critically important.
We’re an energetic group of people – chemists, designers, computer scientists, synthetic biologists, physicians, social media experts, filmmakers, and architects – dedicated to the future of health-awareness and body-based self-expression.
LogicInk is funded by West Ventures, market and brand experts with investor discipline; Village Global, the venture firm backed by some of the world’s most successful entrepreneurs including Bill Gates, Jeff Bezos, and Mark Zuckerberg; and Breakout Labs, a fund within the Thiel Foundation.
Along with Berkeley Catalyst Fund, Krillion Ventures, atypical, Mission Bay Capital, Kendall Ventures, Cloudstone Venture Capital, Marta Bulaich, Elizabeth Weil, Yoshihiro Takasawa, Richard Golob, Peter Yared, Antoine Blondeau, John Zhang, Anatoly Tikhman, James Christopherson, and two Fortune 50 officers.